A study in the journal Vaccine reveals that misinformation and concerns about side effects are leading reasons why over 80% of eligible Americans have skipped
A recent study analyzed TikTok videos with the hashtag “Ozempic,” highlighting the platform’s influence on promoting the weight loss drug. The surge in popularity resulted
Study from JAMA reveals that users of GLP-1 agonists, recent drugs for weight management, show a heightened risk of gastrointestinal complications like intestinal obstruction, gastroparesis,
Some of the country’s top Medicare experts aren’t sold on a new Biden administration plan to enforce stricter staffing requirements in nursing homes. Current federal
Mydecine Innovations Group Inc. (NEO:MYCO) (OTC:MYCOF) (FSE:0NF0) a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company“), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, and Celly
Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to
Reunion Neuroscience Inc., a venture backed clinical-stage biopharmaceutical company committed to developing innovative and patented therapeutic solutions for underserved mental health conditions, today announced that
STAT’s Mohana Ravindranath and Annalisa Merelli will be at HLTH in Las Vegas and will be writing a daily email dispatch from the meeting. Sign